Investor Martin Shkreli, popularly known as “Pharma Bro,” is criticizing President Donald Trump’s latest decision to acquire equity stakes in quantum computing stocks.
Investor Martin Shkreli, popularly known as “Pharma Bro,” is criticizing President Donald Trump’s latest decision to acquire equity stakes in quantum computing stocks.